Status:
COMPLETED
ROGYcare: The Impact of a Cancer Survivorship Care Plan on Patient Reported Outcomes and Health Care Providers
Lead Sponsor:
Lonneke van de Poll-Franse
Collaborating Sponsors:
Comprehensive Cancer Centre The Netherlands
Dutch Cancer Society
Conditions:
Ovarian Cancer
Endometrium Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Earlier diagnoses and improved treatments have contributed to the growing cohort of cancer survivors. Nevertheless, these patients remain at risk for adverse long-term or late physical or psychosocial...
Eligibility Criteria
Inclusion
- Women who are newly diagnosed with endometrial or ovarian cancer in one of the 12 participating hospitals.
- The patients have to be able to complete a Dutch questionnaire.
Exclusion
- Patients who are not able to read or write Dutch will be excluded, as they are not able to complete a Dutch questionnaire.
Key Trial Info
Start Date :
April 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2016
Estimated Enrollment :
396 Patients enrolled
Trial Details
Trial ID
NCT01185626
Start Date
April 1 2011
End Date
July 1 2016
Last Update
May 9 2017
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Jeroen Bosch Ziekenhuis
's-Hertogenbosch, Netherlands, 5211 RW
2
Amphia Ziekenhuis
Breda, Netherlands, 4818 CK & 4901 DH
3
Catharina-Ziekenhuis
Eindhoven, Netherlands, 5623 EJ
4
Maxima Medisch Centrum
Eindhoven, Netherlands, 5631 BM & 5504 DB